KMT2D (lysine methyltransferase 2D)

2003-02-01  

Identity

HGNC
LOCATION
12q13.12
LOCUSID
ALIAS
AAD10,ALR,CAGL114,KABUK1,KMS,MLL2,MLL4,TNRC21
FUSION GENES

Other Information

Locus ID:

NCBI: 8085
MIM: 602113
HGNC: 7133
Ensembl: ENSG00000167548

Variants:

dbSNP: 8085
ClinVar: 8085
TCGA: ENSG00000167548
COSMIC: KMT2D

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000167548ENST00000301067O14686
ENSG00000167548ENST00000526209H0YEF2
ENSG00000167548ENST00000547610F8VWW4
ENSG00000167548ENST00000650290A0A3B3ISC8

Expression (GTEx)

0
5
10
15
20
25
30

Pathways

PathwaySourceExternal ID
Lysine degradationKEGGko00310
Lysine degradationKEGGhsa00310
Signal TransductionREACTOMER-HSA-162582
Signaling by WntREACTOMER-HSA-195721
TCF dependent signaling in response to WNTREACTOMER-HSA-201681
Formation of the beta-catenin:TCF transactivating complexREACTOMER-HSA-201722
Deactivation of the beta-catenin transactivating complexREACTOMER-HSA-3769402
Developmental BiologyREACTOMER-HSA-1266738
Chromatin organizationREACTOMER-HSA-4839726
Chromatin modifying enzymesREACTOMER-HSA-3247509
PKMTs methylate histone lysinesREACTOMER-HSA-3214841
Activation of HOX genes during differentiationREACTOMER-HSA-5619507
Activation of anterior HOX genes in hindbrain development during early embryogenesisREACTOMER-HSA-5617472

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
379212292024Hearing characteristics and otoradiological abnormalities in three patients with novel pathogenic variants of KMT2D-related Kabuki syndrome.1
380150242024EBF2 Links KMT2D-Mediated H3K4me1 to Suppress Pancreatic Cancer Progression via Upregulating KLLN.1
382064142024Macular dystrophy in Kabuki syndrome due to de novo KMT2D variants: refining the phenotype with multimodal imaging and follow-up over 10 years: insight into pathophysiology.0
385280562024DNA methylation profiling in Kabuki syndrome: reclassification of germline KMT2D VUS and sensitivity in validating postzygotic mosaicism.1
386842982024[Clinical and genetic characteristics of four children with Kabuki syndrome due to de novo variants of KMT2D gene].0
379212292024Hearing characteristics and otoradiological abnormalities in three patients with novel pathogenic variants of KMT2D-related Kabuki syndrome.1
380150242024EBF2 Links KMT2D-Mediated H3K4me1 to Suppress Pancreatic Cancer Progression via Upregulating KLLN.1
382064142024Macular dystrophy in Kabuki syndrome due to de novo KMT2D variants: refining the phenotype with multimodal imaging and follow-up over 10 years: insight into pathophysiology.0
385280562024DNA methylation profiling in Kabuki syndrome: reclassification of germline KMT2D VUS and sensitivity in validating postzygotic mosaicism.1
386842982024[Clinical and genetic characteristics of four children with Kabuki syndrome due to de novo variants of KMT2D gene].0
351897942023Pan-Cancer Analysis of Histone Methyltransferase KMT2D with Potential Implications for Prognosis and Immunotherapy in Human Cancer.7
365259732023KMT2D deficiency drives lung squamous cell carcinoma and hypersensitivity to RTK-RAS inhibition.15
366018802023Association of KMT2C/D loss-of-function variants with response to immune checkpoint blockades in colorectal cancer.4
366746082023Mutational Landscape of Bladder Cancer in Mexican Patients: KMT2D Mutations and chr11q15.5 Amplifications Are Associated with Muscle Invasion.1
367018422023MLL4 Regulates the Progression of Non-Small-Cell Lung Cancer by Regulating the PI3K/AKT/SOX2 Axis.2

Citation

Dessen P

KMT2D (lysine methyltransferase 2D)

Atlas Genet Cytogenet Oncol Haematol. 2003-02-01

Online version: http://atlasgeneticsoncology.org/gene/41375/kmt2d-(lysine-methyltransferase-2d)